Company Proteome Sciences plc

Equities

PRM

GB0003104196

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 16:35:11 09/05/2024 BST 5-day change 1st Jan Change
3.36 GBX -4.27% Intraday chart for Proteome Sciences plc -4.27% -25.83%

Business Summary

Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.

Sales per Business

GBP in Million2022Weight2023Weight Delta
Tandem Mass Tag
39.6 %
2 28.3 % 2 39.6 % -9.42%
Biomarker Services
32.4 %
3 35.4 % 2 32.4 % -40.79%
Tandem Mass Tag Royalties
28.0 %
3 36.4 % 1 28.0 % -50.26%

Sales per region

GBP in Million2022Weight2023Weight Delta
United States
76.4 %
6 80.5 % 4 76.4 % -38.63%
European Union
17.0 %
1 14.9 % 1 17.0 % -26.31%
United Kingdom
6.2 %
0 4.2 % 0 6.2 % -5.76%
Other
0.3 %
0 0.3 % 0 0.3 % -32.00%

Managers

Managers TitleAgeSince
Chief Executive Officer 63 14/09/20
Director of Finance/CFO 48 31/08/22
Chairman 71 09/12/93
Chief Tech/Sci/R&D Officer 60 31/12/09
Director/Board Member - 08/02/17
Corporate Secretary - 31/07/17

Members of the board

Members of the board TitleAgeSince
Chairman 71 09/12/93
Director/Board Member 69 30/06/14
Director/Board Member 72 31/07/17
Chief Tech/Sci/R&D Officer 60 31/12/09
Chief Executive Officer 63 14/09/20
Director of Finance/CFO 48 31/08/22
Director/Board Member 62 15/10/14
Director/Board Member - 08/02/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 295,182,056 237,720,343 ( 80.53 %) 0 80.53 %

Shareholders

NameEquities%Valuation
Vulpes Investment Management Pte Ltd.
22.97 %
67,789,772 22.97 % 3 M p
36,915,059 12.51 % 2 M p
ISPartners Investment Solutions AG
6.570 %
19,392,403 6.570 % 830 383 p
Hargreaves Lansdown Asset Management Ltd.
4.225 %
12,471,000 4.225 % 534 008 p
Jarvis Investment Management Ltd.
3.021 %
8,916,000 3.021 % 381 783 p
SpreadEx Ltd.
1.805 %
5,329,000 1.805 % 228 188 p
3,400,000 1.152 % 145 588 p
James Brearley & Sons Ltd.
1.129 %
3,334,000 1.129 % 142 762 p
Rowan Dartington & Co. Ltd. (Broker)
0.7450 %
2,199,000 0.7450 % 94 161 p
1,656,000 0.5610 % 70 910 p

Company contact information

Proteome Sciences Plc

Coveham House Downside Bridge Road

KT11 3EP, Cobham

+44 20 7043 2116

http://www.proteome.co.uk
address Proteome Sciences plc(PRM)

Group companies

NameCategory and Sector
Medical Specialties
  1. Stock Market
  2. Equities
  3. PRM Stock
  4. Company Proteome Sciences plc